The Cigna Raised Its Long-term Average Annual Adjusted EPS Growth Target To 10%-14% And Reaffirmed Its 2024 Adjusted EPS Guidance Of At Least $28.25 Vs. $28.42 Est.
Portfolio Pulse from Benzinga Newsdesk
Cigna has increased its long-term average annual adjusted EPS growth target to 10%-14% and has reaffirmed its 2024 adjusted EPS guidance of at least $28.25, compared to the estimated $28.42.
March 07, 2024 | 11:49 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cigna has raised its long-term adjusted EPS growth target to 10%-14% and reaffirmed its 2024 adjusted EPS guidance of at least $28.25, versus the estimated $28.42.
Raising the long-term EPS growth target and reaffirming the 2024 EPS guidance, despite it being slightly below the estimated $28.42, indicates Cigna's confidence in its financial health and growth prospects. This positive outlook is likely to be viewed favorably by investors, potentially leading to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100